Document Excerpt: The Evolving Role of Medical Affairs in Product Launch: Timelines, Success Factors, and Digital Influence

To return to the study abstract to purchase the full study - click here.

This excerpt includes research findings and metrics from document #5697 "The Evolving Role of Medical Affairs in Product Launch: Timelines, Success Factors, and Digital Influence."

Industries Profiled:
Pharmaceutical; Medical Device; Biotech; Biopharmaceutical; Diagnostic; Health Care; Chemical; Consulting; Consumer Products; Clinical Research; Laboratories; Science


Companies Profiled:
Adamas Pharmaceuticals; AstraZeneca; Alcon; Albireo; Apellis Pharmaceuticals; ASC Therapeutics; Baxter Healthcare; BELLUS Health; Boehringer Ingelheim; BIAL; bioMerieux; Cardinal Health; Cipla; Eisai; EMD Serono; Genentech; Fidia; Eurofarma; GlaxoSmithKline ; GW Pharmaceuticals; Ipsen; Helsinn; Karyopharm Therapeutics; Kyowa Kirin; Labaid Group; Matinas BioPharma; Lundbeck; MEDiSTRAVA; Melinta Therapeutics; Inc; Merck Serono; NextGen Healthcare; Novartis; Pfizer; Pixacore; Gedeon Richter ; Sandoz; Sanofi; Santen; Sunovion; Takeda Pharmaceuticals; Thermo Fisher; Terumo Corporation; Vertex Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.